Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
Clinical trial NCT03426345 · TERMINATED
Trial details
- NCT number
- NCT03426345
- Sponsor
- Allergan
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-16
- Primary completion
- 2020-07-16
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.